MyFinsight
Home
About
Contact
kpti: the balance sheet
Income Statement
|
Cash Flow
|
Balance Sheet
For the quarter ending 2025-09-30, KPTI has $96,232K in assets.
Balance Sheets Overview
00
No enough data to generate the overview
Subscribe for Financial Insights
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Quarterly
123
Balance Sheets
2025-09-30
2025-06-30
Total assets
96,232
104,879
Total stockholders' deficit
-269,258
-238,926
Total liabilities and stockholders' deficit
96,232
104,879
Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Page 1
Subscribe for Financial Insights
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Prepaid expenses and
other current assets
$8,026K
Inventory
$3,966K
Accounts receivable, net
$31,877K
Investments
$8,205K
Cash and cash
equivalents
$37,672K
Other assets
$1,334K
Restricted cash
$350K
Operating lease
right-of-use assets
$4,680K
Property and equipment,
net
$122K
Total current assets
$89,746K
Total assets
$96,232K
Accumulated deficit
-$1,657,301K
Accumulated other
comprehensive loss
-$259K
Total liabilities and
stockholders' deficit
$96,232K
Total stockholders'
deficit
-$269,258K
Additional paid-in capital
$1,388,289K
Common stock, 0.0001
par value 53,333...
$13K
Total liabilities
$365,490K
Other liabilities
$14,118K
Operating lease
liabilities, net of current...
$6,008K
Common stock warrants
$7,965K
Deferred royalty
obligation
$73,499K
Senior secured term
loan, net of current...
$83,895K
Convertible senior notes due
2025, net of current...
$24,246K
Convertible senior notes due
2029
$68,602K
Total current
liabilities
$87,157K
Other current
liabilities
$1,765K
Operating lease
liabilities
$922K
Senior secured term
loan
$12,500K
Convertible senior notes due
2025
$250K
Accrued expenses
$66,328K
Accounts payable
$5,392K
Subscribe for Financial Insights
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)